Clinical trial
Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney…
NCT00459875 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00459875 |
|---|---|
| Title | Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer |
| Official title | Phase II Study of Sunitinib in Patients With Metastatic Papillary Renal Cell Carcinoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | sunitinib malate |
| Enrollment | 24 |
| Start date | Mar 1, 2007 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Apr 13, 2007 |
| Last update posted | Nov 26, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: